Literature DB >> 8439985

T cell killing of human colon carcinomas by monoclonal-antibody-targeted superantigens.

P A Lando1, M Dohlsten, G Hedlund, E Akerblom, T Kalland.   

Abstract

The bacterial superantigen staphylococcal enterotoxin A (SEA) induces T cell activation as well as directing activated T cells to kill major-histocompatibility-complex-class-II-expressing tumours such as freshly prepared leukemia cells. We now report that conjugates of SEA and the colon-carcinoma-reactive mAb C215 mediate T-cell-dependent killing of freshly isolated cells obtained from surgical specimens of human colon carcinomas. Cytotoxicity was observed at nanomolar concentrations of conjugate while no or very low effects were seen with the mAb C215 or SEA alone. Tumour-infiltrating lymphocytes (TIL) did not exert any cytotoxicity against conjugate-treated tumour cells immediately after isolation. In vitro culture of TIL with interleukin-2 and SEA resulted in SEA-mAb-conjugate-dependent killing of freshly isolated tumour cells. This suggests that mAb-SEA conjugates may be of potential use to target T lymphocytes, including TIL, against colon carcinoma cells in vivo.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8439985     DOI: 10.1007/bf01740903

Source DB:  PubMed          Journal:  Cancer Immunol Immunother        ISSN: 0340-7004            Impact factor:   6.968


  32 in total

1.  A recombinant C-terminal fragment of staphylococcal enterotoxin A binds to human MHC class II products but does not activate T cells.

Authors:  G Hedlund; M Dohlsten; T Herrmann; G Buell; P A Lando; S Segrén; J Schrimsher; H R MacDonald; H O Sjögren; T Kalland
Journal:  J Immunol       Date:  1991-12-15       Impact factor: 5.422

2.  Physiologic activation of T cells via the T cell receptor induces NF-kappa B.

Authors:  C Jamieson; P G McCaffrey; A Rao; R Sen
Journal:  J Immunol       Date:  1991-07-15       Impact factor: 5.422

3.  Characterization of activated lymphocytes in colon cancer.

Authors:  E C Ebert; R E Brolin; A I Roberts
Journal:  Clin Immunol Immunopathol       Date:  1989-01

4.  Patterns of human tumor-infiltrating lymphocytes in 120 human cancers.

Authors:  C M Balch; L B Riley; Y J Bae; M A Salmeron; C D Platsoucas; A von Eschenbach; K Itoh
Journal:  Arch Surg       Date:  1990-02

5.  Expression of MHC class I and class II antigens in colonic carcinomas.

Authors:  M Norazmi; A W Hohmann; J M Skinner; J Bradley
Journal:  Pathology       Date:  1989-10       Impact factor: 5.306

6.  Frequency of abnormal expression of HLA-A,B,C and HLA-DR molecules, invariant chain, and LFA-3 (CD58) in colorectal carcinoma and its impact on tumor recurrence.

Authors:  P Möller; K Koretz; P Schlag; F Momburg
Journal:  Int J Cancer Suppl       Date:  1991

7.  Characterization of individual tumor necrosis factor alpha-and beta-producing cells after polyclonal T cell activation.

Authors:  U Andersson; G Adolf; M Dohlsten; G Möller; H O Sjögren
Journal:  J Immunol Methods       Date:  1989-10-24       Impact factor: 2.303

8.  TIL from renal-cell carcinoma: restimulation with tumor influences proliferation and cytolytic activity.

Authors:  J Alexander; P Rayman; M Edinger; R Connelly; R Tubbs; R Bukowski; E Pontes; J Finke
Journal:  Int J Cancer       Date:  1990-01-15       Impact factor: 7.396

9.  Quantitation of proliferative and cytotoxic precursor cells directed against human tumours: limiting dilution analysis in peripheral blood and at the tumour site.

Authors:  B M Vose
Journal:  Int J Cancer       Date:  1982-08-15       Impact factor: 7.396

10.  Expression of MHC class II, interleukin 2 receptor and CD45 antigens on tumour-associated T lymphocytes in colonic carcinoma.

Authors:  M N Norazmi; A W Hohmann; J M Skinner; J Bradley
Journal:  Br J Cancer       Date:  1989-11       Impact factor: 7.640

View more
  7 in total

1.  Co-stimulation with B7 and targeted superantigen is required for MHC class II-independent T-cell proliferation but not cytotoxicity.

Authors:  P A Lando; M Dohlsten; G Hedlund; T Brodin; D Sansom; T Kalland
Journal:  Immunology       Date:  1993-10       Impact factor: 7.397

Review 2.  Bacterial pyrogenic exotoxins as superantigens.

Authors:  M Kotb
Journal:  Clin Microbiol Rev       Date:  1995-07       Impact factor: 26.132

3.  Major histocompatibility complex class I molecule serves as a ligand for presentation of the superantigen staphylococcal enterotoxin B to T cells.

Authors:  A C Häffner; K Zepter; C A Elmets
Journal:  Proc Natl Acad Sci U S A       Date:  1996-04-02       Impact factor: 11.205

4.  Immunotherapy of human colon cancer by antibody-targeted superantigens.

Authors:  M Dohlsten; P A Lando; P Björk; L Abrahmsén; L Ohlsson; P Lind; T Kalland
Journal:  Cancer Immunol Immunother       Date:  1995-09       Impact factor: 6.968

Review 5.  Monoclonal antibodies and superantigens: a novel therapeutic approach.

Authors:  T Kalland; M Dohlsten; P Lind; A Sundstedt; L Abrahmsén; G Hedlund; P Björk; P A Lando; M Björklund
Journal:  Med Oncol Tumor Pharmacother       Date:  1993

6.  Superantigen-SEA gene modified tumor vaccine for hepatocellular carcinoma: an in vitro study.

Authors:  Shao-Ying Lu; Yan-Fang Sui; Zeng-Shan Li; Jing Ye; Hai-Long Dong; Ping Qu; Xiu-Min Zhang; Wen-Yong Wang; Yu-Song Li
Journal:  World J Gastroenterol       Date:  2004-01       Impact factor: 5.742

Review 7.  Targeting of superantigens.

Authors:  T Kalland; M Dohlsten; L Abrahmsén; G Hedlund; P Björk; P A Lando; A Sundstedt; E Akerblom; P Lind
Journal:  Cell Biophys       Date:  1993 Jan-Jun
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.